Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same
AssigneesCurogen Technology Co., Ltd., Research & Business Foundation Sungkyunkwan University
InventorsChang Woo Lee, Jin Kwan Lee, Hyun Soo Kim, Jae-kyung Kim, Joon Sup Yoon
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for preventing or treating liver cancer in a subject comprising administrating at least one selected from the group consisting of an Ssu72 peptide, a polynucleotide encoding the Ssu72 peptide and an expression vector containing the polynucleotide to the subject.
Claims6
A method for treating a patient suffering from liver cancer comprising administering to the patient an adeno-associated virus (AAV) vector comprising a polynucleotide encoding a Ssu72 peptide and a liver-specific promoter operably linked to the polynucleotide, and wherein the AAV vector is administered by a systemic administration or an intrahepatic administration.
Dependencies are inferred from the claim text.